Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

EQ vs ECOR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

EQ Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 8–2 Matrix Metrics)

EQ Overall Winner 6-Pillar Tally: EQ 3 – 2 ECOR (1 Tie) Matrix Metrics: EQ 8 – 2 ECOR

As of Nov 19, 2026, Equillium, Inc. (EQ) is the stronger overall head-to-head candidate over electroCore, Inc. (ECOR) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). EQ carries a Unified Composite Score of 48.0/100 (HOLD) at $1.12 (1.5x Forward P/E, 0.0% operating margin), whereas ECOR carries 56.8/100 (HOLD) at $4.85 (N/M Forward P/E, -33.1% operating margin).

  • Composite vs. Pillar Nuance: While ECOR currently prints a higher short-term Unified Composite Score (56.8/100 HOLD vs. EQ 48.0/100 HOLD), EQ captures the overall institutional head-to-head verdict (8–2 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (0.0% vs. -33.1% operating margin) and revenue trajectory (-52.3% vs. +11.5% YoY).
  • Technical & Structure Timing Caution: EQ is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0); meanwhile ECOR is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About EQ vs ECOR
EQ NASDAQ Head-to-Head Winner
Equillium, Inc. Common Stock
Pharmaceutical Preparations
$1.12
+1.82% 1D
Market Cap $90.6M
TTM Revenue $4.4M
Forward P/E 1.5x
Beta / 30D Vol 1.53β · 93% Vol
Unified Composite Score
48.0 / 100 HOLD
Tech 30.0 Fund 51.0 Flow 63.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -20.8%), weak momentum, RSI 36
RSI-14: 36.0 · SMA20: $1.33 · SMA50: $1.49
ECOR NASDAQ
electroCore, Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.85
-6.19% 1D
Market Cap $47.7M
TTM Revenue $38M
Forward P/E N/M
Beta / 30D Vol 1.52β · 155% Vol
Unified Composite Score
56.8 / 100 HOLD
Tech 68.0 Fund 53.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -11.5%), weak momentum, RSI 32
RSI-14: 31.5 · SMA20: $6.90 · SMA50: $8.67

6-Pillar Scorecard Institutional Category Breakdown (EQ 3 – 2 ECOR)

Columns: Metric · EQ · ECOR
1. Valuation Multiples EQ
Forward P/E 1.5x N/M
Trailing P/E 1.5x N/M
PEG Ratio N/M N/M
EV / Revenue 7.7x 1.4x
2. Growth & Scale ECOR
Revenue Growth (YoY) -52.3% +11.5%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $4.4M $38M
Market Cap $90.6M $47.7M
3. Profitability & Quality EQ
Gross Margin 100.0% 87.7%
Operating Margin 0.0% -33.1%
Net Profit Margin 0.0% -33.5%
Return on Equity (ROE) -59.0% -478.7%
4. Balance Sheet & Cash Flow ECOR
Cash Generation (TTM) -$20M -$6.9M
Cash Flow Margin N/A -18.1%
Net Cash / Leverage $57M Net Cash $4.6M Net Debt
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning EQ
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 261.3% (100th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: EQ (8) vs ECOR (2)
Institutional Metric EQ ECOR Criterion Row Edge
Market Capitalization
Scale
$90.6M $47.7M Larger Scale EQ
Trailing P/E Ratio
Valuation
1.5x N/M Lower Multiple EQ
Forward P/E Ratio
Valuation
1.5x N/M Lower Multiple EQ
Revenue Growth (YoY)
Growth
-52.3% +11.5% Higher Growth ECOR
Operating Margin (TTM)
Profitability
0.0% -33.1% Higher Margin EQ
Net Profit Margin
Profitability
0.0% -33.5% Higher Margin EQ
Return on Equity (ROE)
Capital Efficiency
-59.0% -478.7% Higher ROE EQ
52-Week Range Position
Momentum
11% ($1–$4) 6% ($4–$13) Stronger Trend EQ
Beta / 30D Volatility
Risk Regime
1.53β · 93% Vol 1.52β · 155% Vol Lower Realized Risk EQ
Unified Institutional Score
Composite Signal
48.0 / 100 (HOLD) 56.8 / 100 (HOLD) Higher Composite ECOR
Trailing 12M Revenue (USD)
Operating Scale
$4.4M $38M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% 87.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 7.7x EV/Rev N/M PEG · 1.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$20M ($57M Net Cash) -$6.9M ($4.6M Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon EQ +12.88 pp
EQ: -21.13% · ECOR: -34.01%
3M Horizon EQ +2.38 pp
EQ: -51.52% · ECOR: -53.9%
6M Horizon ECOR +30.29 pp
EQ: -49.32% · ECOR: -19.03%
1Y Horizon EQ +15.96 pp
EQ: +12.0% · ECOR: -3.96%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period EQ Revenue ECOR Revenue EQ Op. Margin ECOR Op. Margin Margin Leader
FY2018 N/A $0M N/A -5494.1% ECOR
FY2019 N/A $0M N/A -1928.2% ECOR
FY2020 N/A $0M N/A -707.9% ECOR
FY2021 N/A $10M N/A -367.7% ECOR
FY2022 $20M $10M -393.9% -266.2% ECOR
FY2023 $40M $20M -40.2% -120.2% EQ
FY2024 $40M $30M -20.1% -48.3% EQ
FY2025 N/A $30M N/A -41.1% ECOR

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
EQ UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 261.3%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact EQ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ECOR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ECOR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
EQ Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $90.6M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ECOR Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $47.7M market capitalization and -33.1% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ EQ vs ECOR Key Questions & Quantitative Answers

As of Nov 19, 2026, Equillium, Inc. (EQ) is the stronger overall head-to-head candidate over electroCore, Inc. (ECOR) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). EQ carries a Unified Composite Score of 48.0/100 (HOLD) at $1.12 (1.5x Forward P/E, 0.0% operating margin), whereas ECOR carries 56.8/100 (HOLD) at $4.85 (N/M Forward P/E, -33.1% operating margin). Composite vs. Pillar Nuance: While ECOR currently prints a higher short-term Unified Composite Score (56.8/100 HOLD vs. EQ 48.0/100 HOLD), EQ captures the overall institutional head-to-head verdict (8–2 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (0.0% vs. -33.1% operating margin) and revenue trajectory (-52.3% vs. +11.5% YoY). Technical & Structure Timing Caution: EQ is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0); meanwhile ECOR is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ECOR leads the Growth & Scale pillar: EQ posts -52.3% YoY revenue growth and +0.0% YoY earnings growth on $4.4M TTM revenue (100.0% gross margin, 0.0% operating margin), compared with ECOR at +11.5% YoY revenue growth and +0.0% YoY earnings growth on $38M TTM revenue (87.7% gross margin, -33.1% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), EQ cumulative revenue shifted +100.0% while ECOR shifted +200.0%. In operating R&D and SG&A reinvestment, EQ deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ECOR.

EQ screens cheaper on headline valuation multiples. EQ trades at 1.5x Forward P/E, 1.5x Trailing P/E, N/M PEG, and 7.7x EV/Revenue (unreported FCF margin), whereas ECOR trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.4x EV/Revenue (-18.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EQ (-59.0% ROE) versus ECOR (-478.7% ROE) capital efficiency.

In options market volatility and institutional positioning, EQ carries 261.3% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.53β · 93% Vol realized risk). By comparison, ECOR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.52β · 155% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.